We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
376
Axsome Therapeutics
AXSM
$12.3B
$3.6M 0.03%
50,084
-45,000
-47% -$3.32M
PEG icon
377
Public Service Enterprise Group
PEG
$39.5B
$3.6M 0.03%
57,467
-20,569
-26% -$1.28M
HSY icon
378
Hershey
HSY
$36.6B
$3.57M 0.03%
14,313
-935
-6% -$245K
ORGN
379
DELISTED
Origin Materials
ORGN
$3.51M 0.03%
27,495
INVH icon
380
Invitation Homes
INVH
$17.6B
$3.48M 0.03%
101,054
-534,093
-84% -$17.8M
ONT
381
Onterris Inc
ONT
$718M
$3.46M 0.03%
82,221
DAWN
382
DELISTED
Day One Biopharmaceuticals
DAWN
$3.46M 0.03%
290,014
+99,821
+52% +$1.3M
TWLO icon
383
Twilio
TWLO
$29.5B
$3.41M 0.02%
53,674
+10,934
+26% +$645K
EWC icon
384
iShares MSCI Canada ETF
EWC
$6.13B
$3.4M 0.02%
97,167
COO icon
385
Cooper Companies
COO
$13.7B
$3.4M 0.02%
35,456
-18,448
-34% -$1.73M
EXPD icon
386
Expeditors International
EXPD
$22.4B
$3.34M 0.02%
27,576
-6,836
-20% -$777K
LNG icon
387
Cheniere Energy
LNG
$53.6B
$3.3M 0.02%
21,668
+330
+2% +$48.9K
EIX icon
388
Edison International
EIX
$30.3B
$3.3M 0.02%
47,470
+1,485
+3% +$104K
AME icon
389
Ametek
AME
$55.7B
$3.28M 0.02%
20,262
+1,015
+5% +$148K
FITB
390
Fifth Third Bancorp
FITB
$51.7B
$3.28M 0.02%
124,954
+31,930
+34% +$823K
TFC icon
391
Truist Financial
TFC
$63.7B
$3.27M 0.02%
107,899
-83,716
-44% -$2.6M
CEG icon
392
Constellation Energy
CEG
$96.4B
$3.27M 0.02%
35,688
+6,559
+23% +$544K
USB icon
393
US Bancorp
USB
$98.9B
$3.26M 0.02%
98,693
-71,704
-42% -$2.32M
AVB icon
394
AvalonBay Communities
AVB
$26.8B
$3.22M 0.02%
17,033
-14,869
-47% -$2.65M
OKE icon
395
Oneok
OKE
$56.4B
$3.21M 0.02%
52,075
KIDS icon
396
OrthoPediatrics
KIDS
$509M
$3.21M 0.02%
73,240
-6,485
-8% -$299K
MSI icon
397
Motorola Solutions
MSI
$70.3B
$3.18M 0.02%
10,859
-9,419
-46% -$2.7M
DLTR icon
398
Dollar Tree
DLTR
$24.1B
$3.17M 0.02%
22,072
-11,120
-34% -$1.64M
LI icon
399
Li Auto
LI
$13.1B
$3.16M 0.02%
90,000
-10,000
-10% -$281K
PSA icon
400
Public Storage
PSA
$60.5B
$3.14M 0.02%
10,746
-8,904
-45% -$2.59M

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.